Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Oncoimmunology|April 22, 2020
Tumor-infiltrating IL-17A<sup>+</sup> cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancerZewei Wang, Quan Zhou, Han Zeng, et al.Cancer Immunology, Immunotherapy : CII|February 14, 2019
Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinomaYing Xiong, Li Liu, Yu Xia, et al.Nature Communications|February 6, 2025
Artificial intelligence links CT images to pathologic features and survival outcomes of renal massesYing Xiong, Linpeng Yao, Jinglai Lin, et al.Journal for Immunotherapy of Cancer|May 7, 2020
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinomaQuan Zhou, Yangyang Qi, Zewei Wang, et al.Cancer Immunology, Immunotherapy : CII|May 6, 2020
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancerTao Wang, Quan Zhou, Han Zeng, et al.Oncoimmunology|September 17, 2020
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5<sup>+</sup> CD8<sup>+</sup> T cell abundanceQiuren Huang, Quan Zhou, Hongyu Zhang, et al.International Journal of Cancer|August 1, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancerQuan Zhou, Hongyu Zhang, Zewei Wang, et al.International Journal of Cancer|October 5, 2019
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responsesHan Zeng, Zheng Liu, Zewei Wang, et al.Nature Communications|April 12, 2024
Growth of millimeter-sized 2D metal iodide crystals induced by ion-specific preference at water-air interfacesJingxian Zhong, Dawei Zhou, Qi Bai, et al.Cancer Immunology, Immunotherapy : CII|November 14, 2019
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic responseYangyang Qi, Yuan Chang, Zewei Wang, et al.Pageof 15